Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Buse Ozcan Kahraman (Izmir, Turkey), Buse Ozcan Kahraman, Sema Savci, Ismail Ozsoy, Serap Acar, Ebru Ozpelit, Can Sevinc, Bahri Akdeniz. Determinants of self-efficacy in patients with pulmonary arterial hypertension: A pilot study. Eur Respir J 2016; 48: Suppl. 60, 4436

Member's Comments

No comment yet.

Related content which might interest you: Impact of insomnia on exercise capacity and quality of life in patients with pulmonary arterial hypertension Source: International Congress 2017 – PAH and CTEPH Year: 2017 Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study Source: Eur Respir J, 50 (1) 1700217; 10.1183/13993003.00217-2017 Year: 2017 Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 608-616 Year: 2011 Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Dipyridamole as adjuvant therapy in patients with pulmonary arterial hypertension. A pilot study Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Self-reported adherence to pulmonary hypertension medications: Preliminary results from a longitudinal cohort study Source: International Congress 2014 – Qualitative and quantitative research that contributes to respiratory nursing practice Year: 2014 Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study Source: ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020 Year: 2021 Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Source: ERJ Open Res, 5 (1) 00218-2018; 10.1183/23120541.00218-2018 Year: 2019 Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multi-centre study Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension Year: 2020 Assessment of quality of life and social and economic impact of the disease in patients with pulmonary arterial hypertension in Germany – Data of the SANTANA-Study Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study Source: Eur Respir J, 57 (2) 2000124; 10.1183/13993003.00124-2020 Year: 2021 Patient engagement and self-management in pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 399-407 Year: 2016 Physician/patient reporting of depression/anxiety in a US pulmonary arterial hypertension population Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Pulmonary arterial hypertension: the burden of disease and impact on quality of life Source: Eur Respir Rev 2015; 24: 621-629 Year: 2015 Psychometric validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012